Join
Live feed
·
INSIDERFilingvia Quantisnow
Neoleukin Therapeutics Inc. logo

SEC Form 4: Smith Sean Michael sold $1,641 worth of shares (1,655 units at $0.99) and converted options into 5,000 shares, increasing direct ownership by 97% to 6,776 units (withholding obligation)

ByQuantisnow·Wall Street's wire, on your screen.
NLTX· Neoleukin Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NLTX (Neoleukin Therapeutics Inc.) and more on Quantisnow.